vs
Side-by-side financial comparison of PUMA BIOTECHNOLOGY, INC. (PBYI) and READING INTERNATIONAL INC (RDI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $50.3M, roughly 1.5× READING INTERNATIONAL INC). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -14.2%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $4.1M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 5.6%).
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.
PBYI vs RDI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.5M | $50.3M |
| Net Profit | — | $-2.6M |
| Gross Margin | 69.3% | — |
| Operating Margin | 22.7% | -1.9% |
| Net Margin | — | -5.1% |
| Revenue YoY | 27.7% | -14.2% |
| Net Profit YoY | — | -14.5% |
| EPS (diluted) | $0.26 | $-0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.5M | $50.3M | ||
| Q3 25 | $54.5M | $52.2M | ||
| Q2 25 | $52.4M | $60.4M | ||
| Q1 25 | $46.0M | $40.2M | ||
| Q4 24 | $59.1M | $58.6M | ||
| Q3 24 | $80.5M | $60.1M | ||
| Q2 24 | $47.1M | $46.8M | ||
| Q1 24 | $43.8M | $45.1M |
| Q4 25 | — | $-2.6M | ||
| Q3 25 | $8.8M | $-4.2M | ||
| Q2 25 | $5.9M | $-2.7M | ||
| Q1 25 | $3.0M | $-4.8M | ||
| Q4 24 | — | $-2.2M | ||
| Q3 24 | $20.3M | $-7.0M | ||
| Q2 24 | $-4.5M | $-12.8M | ||
| Q1 24 | $-4.8M | $-13.2M |
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
| Q4 25 | 22.7% | -1.9% | ||
| Q3 25 | 17.6% | -0.6% | ||
| Q2 25 | 12.7% | 4.8% | ||
| Q1 25 | 8.7% | -17.2% | ||
| Q4 24 | 22.6% | 2.6% | ||
| Q3 24 | 27.4% | -0.6% | ||
| Q2 24 | -4.6% | -16.4% | ||
| Q1 24 | -5.3% | -16.7% |
| Q4 25 | — | -5.1% | ||
| Q3 25 | 16.2% | -8.0% | ||
| Q2 25 | 11.2% | -4.4% | ||
| Q1 25 | 6.5% | -11.8% | ||
| Q4 24 | — | -3.8% | ||
| Q3 24 | 25.2% | -11.7% | ||
| Q2 24 | -9.6% | -27.4% | ||
| Q1 24 | -11.0% | -29.4% |
| Q4 25 | $0.26 | $-0.11 | ||
| Q3 25 | $0.17 | $-0.18 | ||
| Q2 25 | $0.12 | $-0.12 | ||
| Q1 25 | $0.06 | $-0.21 | ||
| Q4 24 | $0.40 | $-0.11 | ||
| Q3 24 | $0.41 | $-0.31 | ||
| Q2 24 | $-0.09 | $-0.57 | ||
| Q1 24 | $-0.10 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $97.5M | $10.5M |
| Total DebtLower is stronger | $22.7M | $185.1M |
| Stockholders' EquityBook value | $130.3M | $-18.2M |
| Total Assets | $216.3M | $434.9M |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $97.5M | $10.5M | ||
| Q3 25 | $94.4M | $8.1M | ||
| Q2 25 | $96.0M | $9.1M | ||
| Q1 25 | $93.2M | $5.9M | ||
| Q4 24 | $101.0M | $12.4M | ||
| Q3 24 | $96.7M | $10.1M | ||
| Q2 24 | $96.8M | $9.3M | ||
| Q1 24 | $107.2M | $7.5M |
| Q4 25 | $22.7M | $185.1M | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | $202.7M | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
| Q4 25 | $130.3M | $-18.2M | ||
| Q3 25 | $115.3M | $-12.1M | ||
| Q2 25 | $104.7M | $-7.7M | ||
| Q1 25 | $97.1M | $-8.1M | ||
| Q4 24 | $92.1M | $-4.4M | ||
| Q3 24 | $71.1M | $1.6M | ||
| Q2 24 | $48.5M | $6.5M | ||
| Q1 24 | $51.0M | $18.0M |
| Q4 25 | $216.3M | $434.9M | ||
| Q3 25 | $202.9M | $435.2M | ||
| Q2 25 | $194.9M | $438.1M | ||
| Q1 25 | $196.2M | $441.0M | ||
| Q4 24 | $213.3M | $471.0M | ||
| Q3 24 | $220.7M | $495.7M | ||
| Q2 24 | $205.0M | $494.9M | ||
| Q1 24 | $214.1M | $494.9M |
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.4M | $4.3M |
| Free Cash FlowOCF − Capex | $14.4M | $4.1M |
| FCF MarginFCF / Revenue | 19.1% | 8.2% |
| Capex IntensityCapex / Revenue | 0.0% | 0.3% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $41.7M | $-2.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.4M | $4.3M | ||
| Q3 25 | $9.7M | $295.0K | ||
| Q2 25 | $14.1M | $1.6M | ||
| Q1 25 | $3.6M | $-7.7M | ||
| Q4 24 | $15.6M | $8.0M | ||
| Q3 24 | $11.0M | $1.3M | ||
| Q2 24 | $1.0M | $-10.4M | ||
| Q1 24 | $11.2M | $-2.8M |
| Q4 25 | $14.4M | $4.1M | ||
| Q3 25 | $9.7M | $-246.0K | ||
| Q2 25 | $14.1M | $1.2M | ||
| Q1 25 | $3.6M | $-8.0M | ||
| Q4 24 | $15.6M | $7.0M | ||
| Q3 24 | $11.0M | $-1.1M | ||
| Q2 24 | $1.0M | $-10.6M | ||
| Q1 24 | — | $-4.7M |
| Q4 25 | 19.1% | 8.2% | ||
| Q3 25 | 17.7% | -0.5% | ||
| Q2 25 | 26.8% | 1.9% | ||
| Q1 25 | 7.7% | -19.8% | ||
| Q4 24 | 26.4% | 12.0% | ||
| Q3 24 | 13.7% | -1.8% | ||
| Q2 24 | 2.1% | -22.7% | ||
| Q1 24 | — | -10.4% |
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 1.0% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.0% | 1.7% | ||
| Q3 24 | 0.0% | 4.0% | ||
| Q2 24 | 0.0% | 0.5% | ||
| Q1 24 | 0.0% | 4.3% |
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PBYI
Segment breakdown not available.
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
